S100A13 and thyroid cancer: Using Stable cell lines with the GFP and S100A13-GFP, we found that overexpression of S100A13 in the transfected thyroid cancer TT cells markedly increased cells proliferate ability, and decreased population percentage of G0/G1 period compared to those cells with either GFP or untransfected TT cells [32].